SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18277910
Source:
http://linkedlifedata.com/resource/pubmed/id/18277910
Search
Subject
(
49
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0400966
pubmed:issue
4
pubmed:dateCreated
2008-3-24
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7910017
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholagogues and Choleretics
,
http://linkedlifedata.com/resource/pubmed/chemical/Glycine
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Peroxisome Proliferator-Activated...
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
,
http://linkedlifedata.com/resource/pubmed/chemical/Ursodeoxycholic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin E
,
http://linkedlifedata.com/resource/pubmed/chemical/muraglitazar
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0192-0790
pubmed:author
pubmed-author:MoseleyRichard HRH
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
332-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18277910-Animals
,
pubmed-meshheading:18277910-Antioxidants
,
pubmed-meshheading:18277910-Cholagogues and Choleretics
,
pubmed-meshheading:18277910-Disease Models, Animal
,
pubmed-meshheading:18277910-Fatty Liver
,
pubmed-meshheading:18277910-Glycine
,
pubmed-meshheading:18277910-Humans
,
pubmed-meshheading:18277910-Hypolipidemic Agents
,
pubmed-meshheading:18277910-Insulin Resistance
,
pubmed-meshheading:18277910-Liver
,
pubmed-meshheading:18277910-Mice
,
pubmed-meshheading:18277910-Oxazoles
,
pubmed-meshheading:18277910-Peroxisome Proliferator-Activated Receptors
,
pubmed-meshheading:18277910-Rats
,
pubmed-meshheading:18277910-Thiazolidinediones
,
pubmed-meshheading:18277910-Treatment Outcome
,
pubmed-meshheading:18277910-Ursodeoxycholic Acid
,
pubmed-meshheading:18277910-Vitamin E
pubmed:year
2008
pubmed:articleTitle
Therapy for nonalcoholic fatty liver disease.
pubmed:publicationType
Editorial